riverhead semaglutide & tirzepatide Microdose Tirzepatide vs. Semaglutide: What's the

GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care This week on On The Pen , we break down a rare FDA walk-back on GLP-1 safety labeling, major pharma signals coming out of JPM 2026, and the growing tension between patient access and legislative efforts that could restrict compounding

Visible weight loss typically begins at weeks 4 to 6, after moving to the 5 mg maintenance dose

Significant weight loss can mess with your menstrual cycle, which may be why some people say that semaglutide affects their periods

Steady-state exposure is achieved following 4 to 5 weeks of once-weekly administration

These symptoms usually stabilize as digestion adjusts to the medication

For psychiatric providers who understand the mind-body connection, this is one of the most natural practice expansions available right now